QL1706

4 registered clinical trials studyying QL1706 — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Efficacy and Safety of QL1706 Combined With Nab-paclitaxel and Cisplatin as 1st Line Therapy for Advanced or M NCT07533305	The First Affiliated Hospital of Henan University of Science and Technology	Phase 2
Not Yet Recruiting	Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and NCT07372079	Tianjin Medical University Cancer Institute and Hospital	Phase 2
Recruiting	QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT NCT07327788	Nanfang Hospital, Southern Medical University	Phase 2
Not Yet Recruiting	QL1706 Plus XELOX as Neoadjuvant Therapy for MSS/pMMR Clinical Stage III Colon Cancer NCT07156682	Qilu Hospital of Shandong University	Phase 2